etilevodopa has been researched along with propantheline in 1 studies
*Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking. [MeSH]
*Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking. [MeSH]
| Studies (etilevodopa) | Trials (etilevodopa) | Recent Studies (post-2010) (etilevodopa) | Studies (propantheline) | Trials (propantheline) | Recent Studies (post-2010) (propantheline) |
|---|---|---|---|---|---|
| 6 | 2 | 2 | 598 | 94 | 28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianucci, AM; Macchia, M; Massarelli, I; Minutolo, F; Prota, G | 1 |
1 other study(ies) available for etilevodopa and propantheline
| Article | Year |
|---|---|
QSAR models for predicting enzymatic hydrolysis of new chemical entities in 'soft-drug' design.
Topics: Algorithms; Combinatorial Chemistry Techniques; Drug Design; Humans; Hydrolysis; Models, Chemical; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Stereoisomerism | 2009 |